Details for New Drug Application (NDA): 210117
✉ Email this page to a colleague
The generic ingredient in ALLOPURINOL is allopurinol sodium. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.
Summary for 210117
Tradename: | ALLOPURINOL |
Applicant: | Zydus Pharms |
Ingredient: | allopurinol |
Patents: | 0 |
Pharmacology for NDA: 210117
Mechanism of Action | Xanthine Oxidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 210117
Suppliers and Packaging for NDA: 210117
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALLOPURINOL | allopurinol | TABLET;ORAL | 210117 | ANDA | Major Pharmaceuticals | 0904-7041 | 0904-7041-61 | 100 BLISTER PACK in 1 CARTON (0904-7041-61) / 1 TABLET in 1 BLISTER PACK |
ALLOPURINOL | allopurinol | TABLET;ORAL | 210117 | ANDA | Cardinal Health 107, LLC | 55154-2338 | 55154-2338-0 | 10 BLISTER PACK in 1 BAG (55154-2338-0) / 1 TABLET in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Oct 12, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
Approval Date: | Oct 12, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription